Literature DB >> 35639865

The effects of exercise and diet on sex steroids in breast cancer survivors.

Justin C Brown1,2,3, Kathleen Sturgeon4, David B Sarwer5, Andrea B Troxel6, Angela M DeMichele7, Crystal S Denlinger8, Kathryn H Schmitz4.   

Abstract

Insufficient physical activity and obesity are associated with an increased risk of cancer recurrence and death in breast cancer survivors. Sex steroid hormones may mediate these associations. This study tested the hypothesis that exercise and diet, as compared to control, favorably change sex steroid hormones. This analysis of data from a subset of participants in a 2 × 2 factorial trial compares 269 postmenopausal breast cancer survivors who were insufficiently physically active and had overweight or obesity and were randomized to one of four treatment groups for 52 weeks: control, exercise alone, diet alone, or exercise plus diet. Secondary sex steroid hormone endpoints included estradiol, sex hormone-binding globulin (SHBG), and testosterone. Treatment effects were quantified using a mixed model for repeated measures. Compared to control, exercise alone did not significantly change estradiol (-1.9%; 95% CI: -12.6, 8.8), SHBG (2.4%; 95% CI: -9.9, 14.6), or testosterone (1.2%; 95% CI: -12.2, 14.5). Compared to control, diet alone did not significantly change estradiol (-7.8%; 95% CI: -17.6, 1.9), SHBG (8.2%; 95% CI: -4.2, 20.6), or testosterone (-0.8%; 95% CI: -13.6, 12.0). Compared to control, exercise plus diet did not significantly change estradiol (-6.3%; 95% CI: -16.3, 3.6), SHBG (8.8%; 95% CI: -4.0, 21.7), or testosterone (-5.3%; 95% CI: -18.0, 7.4). In postmenopausal breast cancer survivors who were insufficiently physically active and had overweight or obesity, randomization to exercise alone, diet alone, or exercise plus diet did not statistically significantly change sex steroid hormone concentrations at week 52.

Entities:  

Keywords:  estradiol; exercise; obesity; sex hormone-binding globulin; testosterone

Mesh:

Substances:

Year:  2022        PMID: 35639865      PMCID: PMC9339480          DOI: 10.1530/ERC-22-0084

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.900


  36 in total

Review 1.  Estrogen and the risk of breast cancer.

Authors:  M Clemons; P Goss
Journal:  N Engl J Med       Date:  2001-01-25       Impact factor: 91.245

2.  Estimation issues in clinical trials and overviews.

Authors:  S J Pocock; M D Hughes
Journal:  Stat Med       Date:  1990-06       Impact factor: 2.373

3.  Estimands in clinical trials - broadening the perspective.

Authors:  Mouna Akacha; Frank Bretz; Stephen Ruberg
Journal:  Stat Med       Date:  2016-07-19       Impact factor: 2.373

4.  Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer.

Authors:  P E Lønning; S I Helle; D C Johannessen; D Ekse; H Adlercreutz
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Aromatase activity and concentrations of cortisol, progesterone and testosterone in breast and abdominal adipose tissue.

Authors:  C J Newton; D L Samuel; V H James
Journal:  J Steroid Biochem       Date:  1986-05       Impact factor: 4.292

Review 6.  Obesity and cancer--mechanisms underlying tumour progression and recurrence.

Authors:  Jiyoung Park; Thomas S Morley; Min Kim; Deborah J Clegg; Philipp E Scherer
Journal:  Nat Rev Endocrinol       Date:  2014-06-17       Impact factor: 43.330

7.  Serum testosterone levels and breast cancer recurrence.

Authors:  Franco Berrino; Patrizia Pasanisi; Cristina Bellati; Elisabetta Venturelli; Vittorio Krogh; Antonio Mastroianni; Edoardo Berselli; Paola Muti; Giorgio Secreto
Journal:  Int J Cancer       Date:  2005-01-20       Impact factor: 7.396

8.  Strategic recruitment of an ethnically diverse cohort of overweight survivors of breast cancer with lymphedema.

Authors:  Kathleen M Sturgeon; Renata Hackley; Anna Fornash; Lorraine T Dean; Monica Laudermilk; Justin C Brown; David B Sarwer; Angela M DeMichele; Andrea B Troxel; Kathryn H Schmitz
Journal:  Cancer       Date:  2017-09-07       Impact factor: 6.860

9.  Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable.

Authors:  Kristin L Campbell; Kerri M Winters-Stone; Joachim Wiskemann; Anne M May; Anna L Schwartz; Kerry S Courneya; David S Zucker; Charles E Matthews; Jennifer A Ligibel; Lynn H Gerber; G Stephen Morris; Alpa V Patel; Trisha F Hue; Frank M Perna; Kathryn H Schmitz
Journal:  Med Sci Sports Exerc       Date:  2019-11       Impact factor: 5.411

10.  Plasma testosterone and prognosis of postmenopausal breast cancer patients.

Authors:  Andrea Micheli; Elisabetta Meneghini; Giorgio Secreto; Franco Berrino; Elisabetta Venturelli; Adalberto Cavalleri; Tiziana Camerini; Maria G Di Mauro; Elena Cavadini; Giuseppe De Palo; Umberto Veronesi; Franca Formelli
Journal:  J Clin Oncol       Date:  2007-06-04       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.